Clinical Trial 42503

Upland, CA 91786


A phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of bimekizumab in subjects with activate ankylosing spondylitis.

Qualified Participants Must:

• Subject is male or female at least 18 years of age
• Including documented radiologic evidence
• Inflammatory back pain for at least 3 months prior to screening visit
• Age at symptoms onset prior to age 45
• Subjects must have at least 1 of the following: Inadequate responce to nsaids therapy, or intolerance to administrationof at least 1 nsaid, or contraindiction to nsaid therapy

Qualified Participants May Receive:

Subjects that qualify and are enrolled into the study will receive the following: doctor evaluation, blood work results, $40.00 per visit completed.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.